Top compounds associated with response to NLGN2


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.002
mRNA CAY10618 CTRPv2 pan-cancer AAC 0.13 0.002
mRNA fluvastatin CTRPv2 pan-cancer AAC 0.13 0.002
mRNA CCT036477 CTRPv2 pan-cancer AAC 0.12 0.002
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.002
mRNA austocystin d CTRPv2 pan-cancer AAC -0.13 0.002
mRNA PD318088 CTRPv2 pan-cancer AAC -0.12 0.003
mRNA CIL70 CTRPv2 pan-cancer AAC 0.16 0.003
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.003
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.003
Download CSV